Khazandi, Manouchehr, Pi, Hongfei, Chan, Wei Yee, Ogunniyi, Abiodun David, Sim, Jowenna Xiao Feng, Venter, Henrietta, Garg, Sanjay, Page, Stephen W., Hill, Peter B., McCluskey, Adam, Trott, Darren J.. Frontiers Research Foundation; 2019. In vitro antimicrobial activity of Robenidine, Ethylenediaminetetraacetic acid and Polymyxin B Nonapeptide against important human and veterinary pathogens.

Nguyen, Hang Thi, Venter, Henrietta, Veltman, Tania, Williams, Ruth, O'Donovan, Lisa Anne, Russell, Cecilia C., McCluskey, Adam, Page, Stephen W., Ogunniyi, Abiodun David, Trott, Darren J.. Elsevier BV; 2021. In vitro synergistic activity of NCL195 in combination with colistin against Gram-negative bacterial pathogens.

Nguyen, Hang Thi, Venter, Henrietta, Woolford, Lucy, Young, Kelly A., Mccluskey, Adam, Garg, Sanjay, Sapula, Sylvia S., Page, Stephen W., Ogunniyi, Abiodun David, Trott, Darren J.. American Society for Microbiology; 2023. Oral administration of a 2-aminopyrimidine robenidine analogue (NCL195) significantly reduces Staphylococcus aureus infection and reduces Escherichia coli infection in combination with sub-inhibitory colistin concentrations in a bioluminescent mouse model.